Condition
Ventral Hernias
Total Trials
6
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed4
Withdrawn1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07451483RecruitingPrimary
Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.
NCT01962480Not ApplicableCompletedPrimary
The Effect of Laparoscopically Closing the Hernia Defect in Laparoscopic Ventral Hernia Repair on Postoperative Pain
NCT01784822CompletedPrimary
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
NCT02730936Not ApplicableWithdrawnPrimary
Antimicrobial Hernia Repair Device
NCT01183325Not ApplicableCompleted
Prospective Evaluation of the Proceed Ventral Patch With and Without Laparoscopic Evaluation
NCT01673568Not ApplicableCompletedPrimary
Abdominal Binder to Reduce Pain and Seroma Formation
Showing all 6 trials